Anti-leishmanial Nanotherapeutics: A Current Perspective
| Autor: | Souvik Sen Gupta, Aditi Shah |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Clinical Biochemistry Context (language use) 02 engineering and technology Genus: Leishmania 03 medical and health sciences Drug Delivery Systems Drug Discovery medicine Effective treatment Animals Humans Nanotechnology Available drugs Intensive care medicine Anti leishmanial Leishmaniasis Pharmacology Leishmania 0303 health sciences Vaccines 030306 microbiology business.industry Vaccine delivery 021001 nanoscience & nanotechnology Drug development Drug delivery Nanoparticles 0210 nano-technology business |
| Zdroj: | Current drug metabolism. 20(6) |
| ISSN: | 1875-5453 |
| Popis: | Background: Leishmaniasis is a dreaded disease caused by protozoan parasites belonging to the genus Leishmania which results in significant morbidity and mortality worldwide. There are no vaccines available currently for the treatment of Leishmaniasis and chemotherapy still remains the mainstay for anti-leishmanial therapeutics. However, toxicity, reduced bioavailability, high cost and chemoresistance are the principal problems which limit the use of the available drugs. In this context, anti-leishmanial nanotherapeutics may show the way for effective treatment of this dreaded disease. Methods: We carried out extensive literature search of bibliographic database using keywords strictly within the scope of the present study for peer reviewed research articles. We focused specifically on articles related to the application of nanotechnology in drug development, drug delivery and vaccine delivery for anti-leishmanial therapeutics. Results: This study shows the immense potential of the application of nanotechnology in the field of anti-leishmanial therapeutics. This will aid the targeted delivery of different drugs which is expected to increase the bioavailability, reduce toxicity and also address the problem of chemoresistance. Conclusion: We surmise that exciting research in the field of anti-leishmanial nanotherapeutics is already showing the promise for effective applicability. Though direct use of nanoparticles as therapeutic agents does not seem to be a good option, the application of nanotechnology in this field for vaccine development is still in its early days. The nano based drug delivery system for anti-leishmanial therapeutics has evolved considerably over the past ten years and holds the potential to drastically change the landscape of anti-leishmanial therapeutics. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|